A citation-based method for searching scientific literature

Peter T Simpson, Jorge S Reis-Filho, Theodora Gale, Sunil R Lakhani. J Pathol 2005
Times Cited: 341







List of co-cited articles
902 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
27

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
24



Repeated observation of breast tumor subtypes in independent gene expression data sets.
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Andrew Nobel, Shibing Deng, Hilde Johnsen, Robert Pesich, Stephanie Geisler,[...]. Proc Natl Acad Sci U S A 2003
16

Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
188
12

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Christina Curtis, Sohrab P Shah, Suet-Feung Chin, Gulisa Turashvili, Oscar M Rueda, Mark J Dunning, Doug Speed, Andy G Lynch, Shamith Samarajiwa, Yinyin Yuan,[...]. Nature 2012
12

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.
Aleix Prat, Joel S Parker, Olga Karginova, Cheng Fan, Chad Livasy, Jason I Herschkowitz, Xiaping He, Charles M Perou. Breast Cancer Res 2010
12

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
12

Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu,[...]. J Clin Oncol 2009
10

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
10

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
9

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.
Christos Sotiriou, Pratyaksha Wirapati, Sherene Loi, Adrian Harris, Steve Fox, Johanna Smeds, Hans Nordgren, Pierre Farmer, Viviane Praz, Benjamin Haibe-Kains,[...]. J Natl Cancer Inst 2006
9

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
9

The molecular pathology of breast cancer progression.
Alessandro Bombonati, Dennis C Sgroi. J Pathol 2011
219
9

Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis.
Peter T Simpson, Theo Gale, Jorge S Reis-Filho, Chris Jones, Suzanne Parry, John P Sloane, Andrew Hanby, Sarah E Pinder, Andrew H S Lee, Steve Humphreys,[...]. Am J Surg Pathol 2005
191
8

Whole-genome analysis informs breast cancer response to aromatase inhibition.
Matthew J Ellis, Li Ding, Dong Shen, Jingqin Luo, Vera J Suman, John W Wallis, Brian A Van Tine, Jeremy Hoog, Reece J Goiffon, Theodore C Goldstein,[...]. Nature 2012
717
8

The landscape of cancer genes and mutational processes in breast cancer.
Philip J Stephens, Patrick S Tarpey, Helen Davies, Peter Van Loo, Chris Greenman, David C Wedge, Serena Nik-Zainal, Sancha Martin, Ignacio Varela, Graham R Bignell,[...]. Nature 2012
8

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. Arch Pathol Lab Med 2014
682
8

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L Baehner, Drew Watson, John Bryant,[...]. J Clin Oncol 2006
8

The life history of 21 breast cancers.
Serena Nik-Zainal, Peter Van Loo, David C Wedge, Ludmil B Alexandrov, Christopher D Greenman, King Wai Lau, Keiran Raine, David Jones, John Marshall, Manasa Ramakrishna,[...]. Cell 2012
867
8

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
Antonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, Karen L Hagerty, D Craig Allred, Richard J Cote, Mitchell Dowsett, Patrick L Fitzgibbons, Wedad M Hanna, Amy Langer,[...]. J Clin Oncol 2007
7

The molecular genetics of breast cancer: the contribution of comparative genomic hybridization.
Jorge S Reis-Filho, Peter T Simpson, Theodora Gale, Sunil R Lakhani. Pathol Res Pract 2005
79
8

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas.
P T Simpson, J S Reis-Filho, M B K Lambros, C Jones, D Steele, A Mackay, M Iravani, K Fenwick, T Dexter, A Jones,[...]. J Pathol 2008
103
7

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.
E de Azambuja, F Cardoso, G de Castro, M Colozza, M S Mano, V Durbecq, C Sotiriou, D Larsimont, M J Piccart-Gebhart, M Paesmans. Br J Cancer 2007
597
7

Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.
Jack Cuzick, Mitch Dowsett, Silvia Pineda, Christopher Wale, Janine Salter, Emma Quinn, Lila Zabaglo, Elizabeth Mallon, Andrew R Green, Ian O Ellis,[...]. J Clin Oncol 2011
489
7


Ductal carcinoma in situ of the breast.
Harold J Burstein, Kornelia Polyak, Julia S Wong, Susan C Lester, Carolyn M Kaelin. N Engl J Med 2004
387
7

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution.
Sohrab P Shah, Ryan D Morin, Jaswinder Khattra, Leah Prentice, Trevor Pugh, Angela Burleigh, Allen Delaney, Karen Gelmon, Ryan Guliany, Janine Senz,[...]. Nature 2009
808
7

Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
H Buerger, F Otterbach, R Simon, C Poremba, R Diallo, T Decker, L Riethdorf, C Brinkschmidt, B Dockhorn-Dworniczak, W Boecker. J Pathol 1999
245
6

High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.
Tarek M A Abdel-Fatah, Desmond G Powe, Zsolt Hodi, Andrew H S Lee, Jorge S Reis-Filho, Ian O Ellis. Am J Surg Pathol 2007
167
6

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies.
Fiona M Blows, Kristy E Driver, Marjanka K Schmidt, Annegien Broeks, Flora E van Leeuwen, Jelle Wesseling, Maggie C Cheang, Karen Gelmon, Torsten O Nielsen, Carl Blomqvist,[...]. PLoS Med 2010
603
6

Histological types of breast cancer: how special are they?
Britta Weigelt, Felipe C Geyer, Jorge S Reis-Filho. Mol Oncol 2010
237
6

Gene-expression signatures in breast cancer.
Christos Sotiriou, Lajos Pusztai. N Engl J Med 2009
959
6


Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ.
Sandra J Shin, Aseem Lal, Sandy De Vries, Junko Suzuki, Ritu Roy, E Shelley Hwang, Stuart J Schnitt, Frederic M Waldman, Yunn-Yi Chen. Hum Pathol 2013
32
18

Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.
Justin M Balko, Jennifer M Giltnane, Kai Wang, Luis J Schwarz, Christian D Young, Rebecca S Cook, Phillip Owens, Melinda E Sanders, Maria G Kuba, Violeta Sánchez,[...]. Cancer Discov 2014
294
6

Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.
T Kuukasjärvi, R Karhu, M Tanner, M Kähkönen, A Schäffer, N Nupponen, S Pennanen, A Kallioniemi, O P Kallioniemi, J Isola. Cancer Res 1997
336
6

Lobular carcinoma in situ: A rare form of mammary cancer.
F W Foote, F W Stewart. Am J Pathol 1941
416
6

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.
Giovanni Ciriello, Michael L Gatza, Andrew H Beck, Matthew D Wilkerson, Suhn K Rhie, Alessandro Pastore, Hailei Zhang, Michael McLellan, Christina Yau, Cyriac Kandoth,[...]. Cell 2015
988
6

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
173
6

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Lyndsay N Harris, Nofisat Ismaila, Lisa M McShane, Fabrice Andre, Deborah E Collyar, Ana M Gonzalez-Angulo, Elizabeth H Hammond, Nicole M Kuderer, Minetta C Liu, Robert G Mennel,[...]. J Clin Oncol 2016
488
6


Histological and molecular types of breast cancer: is there a unifying taxonomy?
Britta Weigelt, Jorge S Reis-Filho. Nat Rev Clin Oncol 2009
257
5



Tiling path genomic profiling of grade 3 invasive ductal breast cancers.
Rachael Natrajan, Maryou B Lambros, Socorro María Rodríguez-Pinilla, Gema Moreno-Bueno, David S P Tan, Caterina Marchió, Radost Vatcheva, Sydonia Rayter, Betania Mahler-Araujo, Laura G Fulford,[...]. Clin Cancer Res 2009
129
5

Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes.
H Buerger, F Otterbach, R Simon, K L Schäfer, C Poremba, R Diallo, C Brinkschmidt, B Dockhorn-Dworniczak, W Boecker. J Pathol 1999
182
5

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.
Pratyaksha Wirapati, Christos Sotiriou, Susanne Kunkel, Pierre Farmer, Sylvain Pradervand, Benjamin Haibe-Kains, Christine Desmedt, Michail Ignatiadis, Thierry Sengstag, Frédéric Schütz,[...]. Breast Cancer Res 2008
618
5

Columnar cell lesions of the breast.
Stuart J Schnitt, Anne Vincent-Salomon. Adv Anat Pathol 2003
166
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.